Last reviewed · How we verify

NCT07082244

Implant Phenotype Modification Via GBR and ADM

Recruiting now NA Last updated 21 August 2025
What this trial tests

NA trial testing Dental implant placement in Horizontal Ridge Deficiency in 40 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
1 July 2026
1 September 2026

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 June 2025
Primary completion1 July 2026
Estimated completion1 September 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Horizontal Ridge Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dental implant placement

Trials testing the same drug.

Other recruiting trials for Horizontal Ridge Deficiency

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07082244.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing